Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?
Darius Babusis(Gilead Sciences (United States)), Raju Subramanian(Gilead Sciences (United States)), Carmen Ip(Gilead Sciences (United States)), Roy Bannister(Gilead Sciences (United States)), Jennifer Leung(Beijing Red Cross Blood Center), Cynthia Kim(Gilead Sciences (United States)), Hoa Thi Le(Gilead Sciences (United States)), Nathan Kozon(MACOM (United States)), Guoju Geng(Gilead Sciences (United States)), John P. Bilello(Global Vaccines (United States)), Rao Kalla(Gilead Sciences (United States)), Jared Pitts(Gilead Sciences (United States)), Dustin S. Siegel(Gilead Sciences (United States)), Xiaofeng Zhao(Gilead Sciences (United States)), Richard L. Mackman(Gilead Sciences (United States)), Bernard P. Murray(Gilead Sciences (United States)), Jesse Yang(Université Bourgogne Franche-Comté)
Cited by 5
Related Papers
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
|Cell Reports|2020|541
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
|Drug Metabolism and Disposition|2002|346
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
|Drug Metabolism and Disposition|2002|325